BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Liu W, Zhu F, Jiang Y, Sun D, Yang B, Yan H. siRNA targeting survivin inhibits the growth and enhances the chemosensitivity of hepatocellular carcinoma cells. Oncology Reports 2013;29:1183-8. [DOI: 10.3892/or.2012.2196] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 2.1] [Reference Citation Analysis]
Number Citing Articles
1 Zhang F, Chu J, Wang F. Expression and clinical significance of cyclooxygenase 2 and survivin in human gliomas. Oncol Lett 2017;14:1303-8. [PMID: 28789345 DOI: 10.3892/ol.2017.6281] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
2 Ye L, Yang Y, Ma XY, Li D, Xu ML, Tan P, Long LM, Wang HQ, Liu T, Guo YH. Construction of a novel vector expressing Survivin-shRNA and fusion suicide gene yCDglyTK and its application in inhibiting proliferation and migration of colon cancer cells. Exp Ther Med 2017;14:4721-8. [PMID: 29201172 DOI: 10.3892/etm.2017.5154] [Reference Citation Analysis]
3 Sun W, Chen G. Impact and mechanism of non-steroidal anti-inflammatory drugs combined with chemotherapeutic drugs on human lung cancer-nude mouse transplanted tumors. Oncol Lett 2016;11:4193-9. [PMID: 27313765 DOI: 10.3892/ol.2016.4493] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
4 Haibara H, Yamazaki R, Nishiyama Y, Ono M, Kobayashi T, Hokkyo-Itagaki A, Nishisaka F, Nishiyama H, Kurita A, Matsuzaki T, Izumi H, Kohno K. YPC-21661 and YPC-22026, novel small molecules, inhibit ZNF143 activity in vitro and in vivo. Cancer Sci 2017;108:1042-8. [PMID: 28192620 DOI: 10.1111/cas.13199] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
5 Han W, Cao F, Gao XJ, Wang HB, Chen F, Cai SJ, Zhang C, Hu YW, Ma J, Gu X, Ding HZ. ZIC1 acts a tumor suppressor in breast cancer by targeting survivin. Int J Oncol 2018;53:937-48. [PMID: 29956756 DOI: 10.3892/ijo.2018.4450] [Cited by in Crossref: 2] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
6 Li J, Yu Y, Zhang Y, Li Z, Cai G, Gong J. Synergy of Raddeanin A and cisplatin induced therapeutic effect enhancement in human hepatocellular carcinoma. Biochemical and Biophysical Research Communications 2017;485:335-41. [DOI: 10.1016/j.bbrc.2017.02.079] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 3.4] [Reference Citation Analysis]
7 Ke W, Wang H, Zhao X, Lu Z. Foeniculum vulgare seed extract exerts anti-cancer effects on hepatocellular carcinoma. Food Funct 2021;12:1482-97. [PMID: 33502415 DOI: 10.1039/d0fo02243h] [Reference Citation Analysis]
8 Luo Y, Liu F, Han S, Qi Y, Hu X, Zhou C, Liang H, Zhang Z. Autophagy-Related Gene Pairs Signature for the Prognosis of Hepatocellular Carcinoma. Front Mol Biosci 2021;8:670241. [PMID: 34095224 DOI: 10.3389/fmolb.2021.670241] [Reference Citation Analysis]
9 Muhammad LA, Saad F. The role of clusterin in prostate cancer: treatment resistance and potential as a therapeutic target. Expert Review of Anticancer Therapy 2015;15:1049-61. [DOI: 10.1586/14737140.2015.1064769] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
10 Mirzaei S, Gholami MH, Hashemi F, Zabolian A, Hushmandi K, Rahmanian V, Entezari M, Girish YR, Sharath Kumar KS, Aref AR, Makvandi P, Ashrafizadeh M, Zarrabi A, Khan H. Employing siRNA tool and its delivery platforms in suppressing cisplatin resistance: Approaching to a new era of cancer chemotherapy. Life Sci 2021;277:119430. [PMID: 33789144 DOI: 10.1016/j.lfs.2021.119430] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
11 Su C. Survivin in survival of hepatocellular carcinoma. Cancer Lett. 2016;379:184-190. [PMID: 26118774 DOI: 10.1016/j.canlet.2015.06.016] [Cited by in Crossref: 47] [Cited by in F6Publishing: 51] [Article Influence: 6.7] [Reference Citation Analysis]
12 Moreno-Càceres J, Fabregat I. Apoptosis in liver carcinogenesis and chemotherapy. Hepat Oncol 2015;2:381-97. [PMID: 30191019 DOI: 10.2217/hep.15.27] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
13 Hu J, Pan J, Luo Z, Tao Z. Downregulation of Survivin by shRNA Inhibits Invasion and Enhances the Radiosensitivity of Laryngeal Squamous Cell Carcinoma. Cell Biochem Biophys 2015;72:251-7. [PMID: 25701406 DOI: 10.1007/s12013-014-0445-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
14 Yu J, Wang Z, Zhang H, Wang Y, Li DQ. Survivin-positive circulating tumor cells as a marker for metastasis of hepatocellular carcinoma. World J Gastroenterol 2021; 27(43): 7546-7562 [PMID: 34887648 DOI: 10.3748/wjg.v27.i43.7546] [Reference Citation Analysis]
15 Qin Q, Cheng H, Lu J, Zhan L, Zheng J, Cai J, Yang X, Xu L, Zhu H, Zhang C, Liu J, Ma J, Zhang X, Dai S, Sun X. Small-molecule survivin inhibitor YM155 enhances radiosensitization in esophageal squamous cell carcinoma by the abrogation of G2 checkpoint and suppression of homologous recombination repair. J Hematol Oncol 2014;7:62. [PMID: 25139395 DOI: 10.1186/s13045-014-0062-8] [Cited by in Crossref: 20] [Cited by in F6Publishing: 24] [Article Influence: 2.5] [Reference Citation Analysis]
16 Yang H, Qiu L, Zhang L, Lv G, Li K, Yu H, Xie M, Lin J. Platinum-zoledronate complex blocks gastric cancer cell proliferation by inducing cell cycle arrest and apoptosis. Tumour Biol 2016;37:10981-92. [PMID: 26891667 DOI: 10.1007/s13277-016-4977-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
17 Mohamed MS, Bishr MK, Almutairi FM, Ali AG. Inhibitors of apoptosis: clinical implications in cancer. Apoptosis 2017;22:1487-509. [PMID: 29067538 DOI: 10.1007/s10495-017-1429-4] [Cited by in Crossref: 62] [Cited by in F6Publishing: 65] [Article Influence: 15.5] [Reference Citation Analysis]
18 Lin P, He RQ, Dang YW, Wen DY, Ma J, He Y, Chen G, Yang H. An autophagy-related gene expression signature for survival prediction in multiple cohorts of hepatocellular carcinoma patients. Oncotarget 2018;9:17368-95. [PMID: 29707114 DOI: 10.18632/oncotarget.24089] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
19 Xu J, Wang Y, Li Z, Wang Q, Zhou X, Wu W. Ultrasound-Targeted Microbubble Destruction (UTMD) Combined with Liposome Increases the Effectiveness of Suppressing Proliferation, Migration, Invasion, and Epithelial- Mesenchymal Transition (EMT) via Targeting Metadherin (MTDH) by ShRNA. Med Sci Monit 2019;25:2640-8. [PMID: 30969950 DOI: 10.12659/MSM.912955] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
20 Charbe NB, Amnerkar ND, Ramesh B, Tambuwala MM, Bakshi HA, Aljabali AAA, Khadse SC, Satheeshkumar R, Satija S, Metha M, Chellappan DK, Shrivastava G, Gupta G, Negi P, Dua K, Zacconi FC. Small interfering RNA for cancer treatment: overcoming hurdles in delivery. Acta Pharm Sin B 2020;10:2075-109. [PMID: 33304780 DOI: 10.1016/j.apsb.2020.10.005] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
21 Shen S, Wang R, Qiu H, Li C, Wang J, Xue J, Tang Q. Development of an Autophagy-Based and Stemness-Correlated Prognostic Model for Hepatocellular Carcinoma Using Bulk and Single-Cell RNA-Sequencing. Front Cell Dev Biol 2021;9:743910. [PMID: 34820373 DOI: 10.3389/fcell.2021.743910] [Reference Citation Analysis]